Search research articles
Contact Us
Filters
Showing results (151-160 of 194) with videos related to
Page
of 20
Sort By:
Journal of Cardiovascular Translational Research
|
June 24, 2025
Development of a Nomogram Model to Predict the Risk of Postoperative Delirium in Cardiac Surgery Patients
Zikomo Gaudence Kipanga, Zexiang Bao, Marvel Gyeyock Tella, et al.
Liver Cancer
|
November 1, 2021
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Zhenggang Ren, Shukui Qin, Zhiqiang Meng, et al.
Frontiers in Endocrinology
|
May 7, 2026
Development and validation of an interpretable machine learning model for predicting in-hospital hypoglycemia in adults with type 1 diabetes mellitus: a multicenter retrospective study
Qiang Zhang, Salama Habibu Saad, Haojie Zhou, et al.
Journal of Clinical Monitoring and Computing
|
September 21, 2024
Practical prognostic tools to predict the risk of postoperative delirium in older patients undergoing cardiac surgery: visual and dynamic nomograms
Chernor Sulaiman Bah, Bongani Mbambara, Xianhai Xie, et al.
The Lancet. Oncology
|
March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Shukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Cancer Letters
|
December 8, 2019
FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
Chao Liu, Yan Zhao, Jianing Wang, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 7, 2022
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
Honghu Tang, Beibei Cui, Yiyu Chen, et al.
Cell Death and Differentiation
|
December 6, 2019
Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Chao Liu, Zhaoying Yao, Jianing Wang, et al.
Cell Death and Differentiation
|
February 7, 2020
Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Chao Liu, Zhaoying Yao, Jianing Wang, et al.
Cancer Medicine
|
April 21, 2023
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study
Dan Liu, Furong Kou, Jifang Gong, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 194) with videos related to
Sort By:
Page
of 20
Journal of Cardiovascular Translational Research
|
June 24, 2025
Development of a Nomogram Model to Predict the Risk of Postoperative Delirium in Cardiac Surgery Patients
Zikomo Gaudence Kipanga, Zexiang Bao, Marvel Gyeyock Tella, et al.
Liver Cancer
|
November 1, 2021
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Zhenggang Ren, Shukui Qin, Zhiqiang Meng, et al.
Frontiers in Endocrinology
|
May 7, 2026
Development and validation of an interpretable machine learning model for predicting in-hospital hypoglycemia in adults with type 1 diabetes mellitus: a multicenter retrospective study
Qiang Zhang, Salama Habibu Saad, Haojie Zhou, et al.
Journal of Clinical Monitoring and Computing
|
September 21, 2024
Practical prognostic tools to predict the risk of postoperative delirium in older patients undergoing cardiac surgery: visual and dynamic nomograms
Chernor Sulaiman Bah, Bongani Mbambara, Xianhai Xie, et al.
The Lancet. Oncology
|
March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Shukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Cancer Letters
|
December 8, 2019
FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
Chao Liu, Yan Zhao, Jianing Wang, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 7, 2022
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
Honghu Tang, Beibei Cui, Yiyu Chen, et al.
Cell Death and Differentiation
|
December 6, 2019
Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Chao Liu, Zhaoying Yao, Jianing Wang, et al.
Cell Death and Differentiation
|
February 7, 2020
Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Chao Liu, Zhaoying Yao, Jianing Wang, et al.
Cancer Medicine
|
April 21, 2023
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study
Dan Liu, Furong Kou, Jifang Gong, et al.
Page
of 20